1 terminated, 1 withdrawn. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Voxelotor Oral Tablet: new trials by email Literature Review of Voxelotor Oral Tablet trials Research Report on Voxelotor Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Voxelotor Brain Oxygenation and Neurocognitive Study Voxelotor Oral Tablet - Sickle Cell Disease | Phase 4 | Withdrawn | Pfizer | 2023-08-09 | 2024-08-09 | |
| Resolution of Sickle Cell Leg Ulcers With Voxelotor Voxelotor Oral Tablet, Placebo - Sickle Cell Disease, Leg Ulcers | Phase 3 | Terminated | Pfizer | 88 | 2022-05-30 | 2025-07-09 |
Anemia, Sickle Cell (2) · Leg Ulcer (1)
Pfizer (2)
Brazil (1) · Kenya (1) · Nigeria (1) · United States (1)